Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases

THOUSAND OAKS, Calif. and WATERTOWN, Mass.: THOUSAND OAKS, Calif. and WATERTOWN, Mass., Oct. 7, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company pioneering precision medicines for brain diseases, announced a strategic collaboration to advance neuroscience discovery, development and commercialization. The companies will collaborate...

Click to view original post